At the May 2016 annual meeting of the American Society for Cataract and Refractive Surgery – the medical organization of surgeons specializing in vision correction and cataract surgeries – updates of several high-profile research studies of LASIK safety and performance, including the FDA PROWL study, were presented showing impressively and consistently high marks for safety, outcomes, as well as patient satisfaction.
What do these data mean for the person considering LASIK?
Ultimately, these studies support the overwhelming body of clinical evidence proving LASIK is a safe and effective vision correction option for those who qualify. Remarkably, these studies report the procedure is more likely to help symptoms of dry eye, glare, halo, starbursts and ghosting than it is to cause symptoms.
Two results of two studies in particular, the U.S. Food and Drug Administration-sponsored “Patient Reported Outcomes with LASIK (PROWL)” and an evaluation of the available scientific literature worldwide on advanced LASIK entitled, “Modern LASIK Outcomes: A Review,” conducted by ASCRS president Kerry Solomon, M.D., have been much anticipated by vision correction surgeons.
“Although each take a different investigative approach, these studies provide some of the best data and insights into LASIK, particularly from the patient’s perspective,” said Daniel S. Durrie, M.D. and one of the clinical investigators for the FDA PROWL study. “One of the key findings, from both studies, is with modern equipment, modern techniques and well-selected patients, good surgeons can deliver terrific results with a high degree of safety. LASIK is a great procedure.”
The FDA PROWL research was conducted as prospective, post-market, observational studies designed to develop and evaluate a patient reported outcome questionnaire for use post-LASIK. Approximately 574 subjects (262 active-duty military personnel, 312 civilians from 5 investigational sites) were enrolled and asked to fill out an online questionnaire before LASIK and 3-months after LASIK.
The “Modern LASIK Outcomes: A Review” updated the work from the “LASIK World Literature Review: Quality of Life and Patient Satisfaction published in 2009 by analyzing the impact of advanced treatment profiles in LASIK (employing femtosecond laser keratomes and wavefront diagnostic/guidance). In the current work, nearly 4500 clinical study papers on the topic of LASIK were evaluated for relevancy and authority. The final data set included 97 high-quality studies that combined represented 67,893 procedures.
These substantial studies made fresh inquiries into the basics of LASIK: Is it safe? Does the procedure improve vision? What is the potential for side effects? The findings from these studies affirmed the consensus of previous research into LASIK performance:
- Patient satisfaction rate of up to 98 percent.
- Nearly 100 percent of patients achieving at least 20/40 vision, with more than 90 percent achieving 20/20 vision.
- Less than 1 percent of patients lost two or more lines (on the eye chart) of best corrected visual acuity (BCVA).
There was particularly good news out of the FDA PROWL study about the potential for side effects, including dry eye and other visual symptoms such as glare, starbursts, ghosting and halos, post LASIK.
- For dry eye, more than half of patients (59%) with dry eye symptoms before surgery reported having no symptoms of dry eye 3-months after LASIK. For those reporting residual dry eye symptoms, there were statistically significant decreases in the severity of symptoms at 3 months post LASIK
- For those patients with no symptoms of dry eye prior to surgery, approximately 30 percent reported experiencing symptoms at 3 months after LASIK. The typical clinical experience with dry eye post LASIK is a gradual improvement of symptoms throughout the healing process, up to one year after surgery.
- LASIK also benefitted those with visual symptoms (glare, starbursts, ghosting and halos) before surgery. More than twice the number of patients reported their pre-operative visual symptoms were gone at 3-months than those who reported an increase in symptoms at 3-months.
While a small percentage of patients may experience symptoms during the healing process, by working closely with your surgeon your symptoms can be managed and, if needed, treated to help you achieve your vision goal.
The results of these studies are consistent with the clinical experience of LASIK and underscore the commitment of surgeons and researchers to continually investigate the potential of this valuable option in vision correction. Through efforts such as these, clinicians are able to find ways to improve the technology, technique and overall patient experience with LASIK, making an already good procedure even better.
This information is provided by the American Refractive Surgery Council.
Leading ophthalmologist, Dr. Neil B. Griffin is an active member of ARSC and uses the latest and most advanced lasers. We are currently the only center who offers an on-site LASIK Suite in the local region. Griffin Eye Center is the first in South Carolina to offer the latest advancements of both the Wavelight® EX500 excimer laser and the VisuMax® laser. The laser speed and accuracy allow Dr. Griffin the ability to expand treatment capabilities, enhancements of current treatments, broaden range of correction and provide the ultimate outcomes for our patients seeking LASIK surgery in Myrtle Beach, South Carolina, and North Carolina area.
Dr. Griffin is board certified, and fellowship trained. He is an active member of American Society of Cataract and Refractive Surgery (ASCRS), American Refractive Surgery Council (ARSC), American-European Congress of Ophthalmic Surgery (AECOS), and the International Society of Refractive Surgery (ISRS).